Fracture risk in perimenopausal women treated with beta-blockers

Calcified Tissue International

Volumn 75, Issue 5, 2004, Pages 365-372

  Rejnmark, Lars ^a   Vestergaard, Peter ^a   Kassem, Moustapha ^b   Christoffersen, Bo Rud ^c   Kolthoff, Niels ^d   Brixen, Kim ^b   Mosekilde, Leif ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

^c HVIDOVRE HOSPITAL   (Denmark)

^d HILLERØD HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CALCIUM CHANNEL BLOCKING AGENT; LOOP DIURETIC AGENT; METOPROLOL; NEUROLEPTIC AGENT; OSTEOCALCIN; PROPRANOLOL; SOTALOL; THIAZIDE DIURETIC AGENT;

ADULT; ARTICLE; BONE DENSITY; BONE MINERAL; BONE TURNOVER; CLIMACTERIUM; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FEMUR NECK; FRACTURE; HUMAN; LOGISTIC REGRESSION ANALYSIS; LUMBAR SPINE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR;

ADRENERGIC BETA-ANTAGONISTS; ANTHROPOMETRY; BONE AND BONES; BONE DENSITY; CASE-CONTROL STUDIES; COHORT STUDIES; CREATININE; CROSS-SECTIONAL STUDIES; DENMARK; FEMALE; FEMUR NECK; FRACTURES, BONE; HUMANS; LOGISTIC MODELS; LUMBAR VERTEBRAE; MIDDLE AGED; ODDS RATIO; OSTEOCALCIN; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RISK FACTORS; TIME FACTORS;

EID: 11944251006     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00223-004-0222-x     Document Type: Article

References (37)

1. Moore RE, Smith CK, Bailey CS, Voelkel EF, Tashjian AH Jr (1993) Characterization of beta-adrenergic receptors on rat and human osteoblast-like cells and demonstration that beta-receptor agonists can stimulate bone resorption in organ culture. Bone Miner 23:301-315
2. Takeda S, Elefteriou F, Levasseur R, Liu X, Zhao L, Parker KL, Armstrong D, Ducy P, Karsenty G (2002) Leptin regulates bone formation via the sympathetic nervous system. Cell 111:305-317
3. Togari A (2002) Adrenergic regulation of bone metabolism: possible involvement of sympathetic innervation of osteoblastic and osteoclastic cells. Microsc Res Tech 58:77-84
4. Herskovits MS, Singh IJ (1984) Effect of guanethidine-induced sympathectomy on osteoblastic activity in the rat femur evaluated by 3H-proline autoradiography. Acta Anat (Basel) 120:151-155
5. Minkowitz B, Boskey AL, Lane JM, Pearlman HS, Vigorita VJ (1991) Effects of propranolol on bone metabolism in the rat. J Orthop Res 9:869-875
6. Takeuchi T, Tsuboi T, Arai M, Togari A (2001) Adrenergic stimulation of osteoclastogenesis mediated by expression of osteoclast differentiation factor in MC3T3-E1 osteoblast-like cells. Biochem Pharmacol 61:579-586
7. Majeska RJ, Minkowitz B, Bastian W, Einhorn TA (1992) Effects of beta-adrenergic blockade in an osteoblast-like cell line. J Orthop Res 10:379-384
8. Cornish J, Callon KE, Bava U, et al. (2002) Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo. J Endocrinol 175:405-415
9. Ducy P, Amling M, Takeda S, et al. (2000) Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 100:197-207
10. Mosekilde L, Jastrup B, Melsen F, Lund B, Sørensen OH, Nielsen HE, Yde H (1984) Effect of propranolol treatment on bone mass, bone mineral content, bone remodelling, parathyroid function and vitamin D metabolism in hyperthyroidism. Eur J Clin Invest 14:96-102
11. Pasco JA, Henry MJ, Sanders KM, Kotowicz MA, Seeman E, Nicholson GC (2004) Beta-adrenergic blockers reduce the risk of fracture partly by increasing bone mineral density: Geelong Osteoporosis Study. J Bone Miner Res 19:19-24
12. Mosekilde L, Hermann AP, Beck NH, Charles P, Nielsen SP, Sorensen OH (1999) The Danish Osteoporosis Prevention Study (DOPS): project design and inclusion of 2000 normal perimenopausal women. Maturitas 31:207-219
13. Jadad AR (1998) Randomised Controlled Trials. A user's guide. BMJ Books, London
14. Vestergaard P, Hermann AP, Gram J, Jensen LB, Kolthoff N, Abrahamsen B, Brot C, Eiken P (1997) Improving compliance with hormonal replacement therapy in primary osteoporosis prevention. Maturitas 28:137-145
15. Moller A (1989) Food composition tables. Publication No. SC3. The Danish National Food Agency, Copenhagen
16. Lund B, Sorensen OH (1979) Measurement of 25-hydroxyvitamin D in serum and its relation to sunshine, age and vitamin D intake in the Danish population. Scand J Clin Lab Invest 39:23-30
17. Charles P, Poser JW, Mosekilde L, Jensen FT (1985) Estimation of bone turnover evaluated by 47Ca-kinetics. Efficiency of serum bone gamma-carboxyglutamic acid-containing protein, serum alkaline phosphatase, and urinary hydroxyproline excretion. J Clin Invest 76:2254-2258
18. Brixen K, Nielsen HK, Eriksen EF, Charles P, Mosekilde L (1989) Efficacy of wheat germ lectin-precipitated alkaline phosphatase in serum as an estimator of bone mineralization rate: comparison to serum total alkaline phosphatase and serum bone Gla-protein. Calcif Tissue Int 44:93-98
19. Pataki A, Muller K, Bilbe G, Green JR, Glatt M (1996) Anabolic effects of beta-2-agonists, formoterol and salbutamol on cancellous bone of ovariectomized (OVX) rat. Bone 9:A116
20. Olsson C, Petersson C, Nordquist A (2003) Increased mortality after fracture of the surgical neck of the humerus: a case-control study of 253 patients with a 12-year follow-up. Acta Orthop Scand 74:714-717
21. Johnell O, Kanis JA, Oden A, Sernbo I, Redlund-Johnell I, Petterson C, De Laet C, Jonsson B (2004) Mortality after osteoporotic fractures. Osteoporos Int 15:38-42
22. Ingle BM, Hay SM, Bottjer HM, Eastell R (1999) Changes in bone mass and bone turnover following ankle fracture. Osteoporos Int 10:408-415
23. Dirschl DR, Henderson RC, Oakley WC (1997) Accelerated bone mineral loss following a hip fracture: a prospective longitudinal study. Bone 21:79-82
24. Petersen MM, Gehrchen PM, Nielsen PK, Lund B (1997) Loss of bone mineral of the hip assessed by DEXA following tibial shaft fractures. Bone 20:491-495
25. Benovic JL, Staniszewski C, Mayor F Jr, Caron MG, Lefkowitz RJ (1988) Beta-adrenergic receptor kinase. Activity of partial agonists for stimulation of adenylate cyclase correlates with ability to promote receptor phosphorylation. J Biol Chem 263:3893-3897
26. Boguslawski G, Hale LV, Yu XP, Miles RR, Onyia JE, Santerre RF, Chandrasekhar S (2000) Activation of osteocalcin transcription involves interaction of protein kinase A- and protein kinase C-dependent pathways. J Biol Chem 275:999-1006
27. Yu XP, Chandrasekhar S (1997) Parathyroid hormone (PTH 1-34) regulation of rat osteocalcin gene transcription. Endocrinology 138:3085-3092
28. Horwitz MJ, Tedesco MB, Gundberg C, Garcia-Ocana A, Stewart AF (2003) Short-term, high-dose parathyroid hormone-related protein as a skeletal anabolic agent for the treatment of postmenopausal osteoporosis. J Clin Endocrinol Metab 88:569-575
29. Cosman F, Nieves J, Woelfert L, Shen V, Lindsay R (1998) Alendronate does not block the anabolic effect of PTH in postmenopausal osteoporotic women. J Bone Miner Res 13:1051-1055
30. Steinichel T, Christiansen P, Vesterby A, Ullerup R, Hessov I, Mosekilde LE, Melsen F (2000) Primary hyperparathyroidism: bone structure, balance, and remodeling before and 3 years after surgical treatment. Bone 26:535-543
31. Kanatani M, Sugimoto T, Kaji H, Ikeda K, Chihara K (2001) Skeletal responsiveness to parathyroid hormone in pseudohypoparathyroidism. Eur J Endocrinol 144:263-269
32. Mortensen L, Hyldstrup L, Charles P (1997) Effect of vitamin D treatment in hypoparathyroid patients: a study on calcium, phosphate and magnesium homeostasis. Eur J Endocrinol 136:52-60
33. Kruse K, Kracht U, Wohlfart K, Kruse U (1989) Biochemical markers of bone turnover, intact serum parathyroid hormone and renal calcium excretion in patients with pseudohypoparathyroidism and hypoparathyroidism before and during vitamin D treatment. Eur J Pediatr 148:535-539
34. Tsuda K, Nishio I, Masuyama Y (2001) Bone mineral density in women with essential hypertension. Am J Hyperten 14:704-707
35. Hanley DA, Brown JP, Tenenhouse A, et al. (2003) Associations among disease conditions, bone mineral density, and prevalent vertebral deformities in men and women 50 years of age and older: cross-sectional results from the Canadian Multicentre Osteoporosis Study. J Bone Miner Res 18:784-790
36. Felson DT, Sloutskis D, Anderson JJ, Anthony JM, Kiel DP (1991) Thiazide diuretics and the risk of hip fracture. Results from the Framingham Study. JAMA 265:370-373
37. LaCroix AZ, Wienpahl J, White LR, Wallace RB, Scherr PA, George LK, Cornoni Huntley J, Ostfeld AM (1990) Thiazide diuretic agents and the incidence of hip fracture. N Engl J Med 322:286-290